Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DexCom, a medical device company, has received CE Mark approval for the Seven, its seven-day continuous glucose monitoring system, enabling commercialization of the system in the EU and the countries in Asia and Latin America that recognize the CE Mark.
Subscribe to our email newsletter
The Seven is DexCom’s second generation device designed to help people with diabetes better manage their diabetes and control their glucose levels.
Terrance Gregg, president and CEO of DexCom, said: “We are pleased to have CE Mark approval for the Seven and we look forward to working with physicians, nurses and diabetes educators to bring this important technology to patients around the world. We hope to initiate a limited launch of Seven in Europe before the end of 2008 and a more robust launch in 2009.”